Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | C7R.CD30.CAR-EBVS T-cells |
| Trade Name | |
| Synonyms | C7R.CD30.CAR-EBVST cells |
| Drug Descriptions |
C7R.CD30.CAR-EBVS T-cells are allogeneic Epstein Barr virus-specific T-cells (EBVSTs) engineered to express a chimeric antigen receptor (CAR) recognizing CD30, IL7R, and an inducible caspase 9 (iC9), which potentially inhibits tumor growth (NCI Thesaurus). |
| DrugClasses | CD30 (TNFRSF8) Immune Cell Therapy 5 |
| CAS Registry Number | NA |
| NCIT ID | C224841 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| C7R.CD30.CAR-EBVS T-cells | C7R.CD30.CAR-EBVS T-cells | 0 | 2 |